271 results on '"Ishii, Kuniaki"'
Search Results
2. The large part German medicine has played in the development of experimental pharmacology in Japan
3. ALOX12 mutation in a family with dominantly inherited bleeding diathesis
4. Bioinformatic Identification of Potential RNA Alterations on the Atrial Fibrillation Remodeling from Human Pulmonary Veins
5. Structural Variants of Midnolin, a Genetic Risk Factor for Parkinson’s Disease, in a Yamagata Cohort
6. Identifying the core concepts of pharmacology education: A global initiative
7. Midnolin regulates the transcriptional activity of early growth response 1
8. A novel genetic risk factor, Midnolin, promotes neurite outgrowth in PC12 cells.
9. The large part German medicine has played in the development of experimental pharmacology in Japan
10. Identifying the core concepts of pharmacology education: a global initiative
11. Comparative Study of Transcriptome in the Hearts Isolated from Mice, Rats, and Humans
12. Preferential Expression of Ca2+-Stimulable Adenylyl Cyclase III in the Supraventricular Area, including Arrhythmogenic Pulmonary Vein of the Rat Heart
13. Differential Inhibition by the Phosphatase Inhibitor Cantharidin of the Anti-adrenergic Effect of Endothelin-1 and Carbachol in the Canine Ventricular Myocardium
14. Endocytic Regulation of Voltage-Dependent Potassium Channels in the Heart
15. Insulin Enhances Gene Expression of Midnolin, a Novel Genetic Risk Factor for Parkinson’s Disease, via Extracellular Signal-Regulated Kinase, Phosphoinositide 3-Kinase and Multiple Transcription Factors in SH-SY5Y Cells
16. Artificial Modulation of Potassium Channels
17. Comparative Study of Transcriptome in the Hearts Isolated from Mice, Rats, and Humans
18. Insulin promotes expression of MIDN, a novel genetic risk factor for Parkinson‘s Disease, mediated through AP-1
19. Insulin suppresses IKs (KCNQ1/KCNE1) currents, which require β-subunit KCNE1
20. JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias.
21. Selective Stimulation of High-Affinity β1-Receptors: Its Implication in the Treatment of Mild Heart Failure
22. Wortmannin Inhibits the Increase in Myofilament Ca2+ Sensitivity Induced by Cross-Talk of Endothelin-1 With Norepinephrine in Canine Ventricular Myocardium
23. JCS/JHRS2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
24. Preferential Expression of Ca 2+ -Stimulable Adenylyl Cyclase III in the Supraventricular Area, including Arrhythmogenic Pulmonary Vein of the Rat Heart.
25. Azelnidipine treatment reduces the expression of Cav1.2 protein
26. Cross-talk between β1-adrenoceptors and ETA receptors in modulation of the slow component of delayed rectifier K+ currents
27. Angiotensin II increases L-type Ca2+ current in gramicidin D-perforated adult rabbit ventricular myocytes: comparison with conventional patch-clamp method
28. Reply to: MIDN locus structural variants and Parkinson’s disease risk
29. Inactivation of the A-type current is inhibited by ERK5 phosphorylation of Kv4.2 in PC12 cells.
30. Midnolin is a strong genetic risk factor for Parkinson's disease in Japanese and British populations.
31. Molecular identification of HSPA8 as an accessory protein of a hyperpolarization-activated chloride channel from rat pulmonary vein cardiomyocytes
32. KCNQ1 is internalized by activation of α1 adrenergic receptors
33. Differential Inhibition by the Phosphatase Inhibitor Cantharidin of the Anti-adrenergic Effect of Endothelin-1 and Carbachol in the Canine Ventricular Myocardium
34. Mutations in the SLC34A2 Gene Are Associated with Pulmonary Alveolar Microlithiasis
35. Differential Inotropic Effects of Endothelin-1, Angiotensin II, and Phenylephrine Induced by Crosstalk With cAMP-Mediated Signaling Process in Dog Ventricular Myocardium
36. Peritumoral CpG Oligodeoxynucleotide Treatment Inhibits Tumor Growth and Metastasis of B16F10 Melanoma Cells
37. Differential inhibition by TAK-044 of the inotropic effects of endothelin-1 and endothelin-3
38. Chapter 4 Permeation of Voltage-Dependent Potassuim Channels
39. Midnolin is a confirmed genetic risk factor for Parkinson’s disease
40. Midnolin promotes neurite outgrowth and expression of parkin ubiquitin ligase, and is associated with Parkinson's Disease.
41. Overexpression of KCNK9 exerts anti- and pro-apoptotic effect on PANC1 cells
42. C3 Production of Cultured Human Epidermal Keratinocytes is Enhanced by IFNγ and TNFα through Different Pathways
43. An amino acid residue whose change by mutation affects drug binding to the HERG channel
44. Overexpression of KCNK9 exerts anti- and pro-apoptotic effect on PANC1 cells
45. ERK5 Phosphorylates Kv4.2 and Inhibits Inactivation of the A-Type Current in PC12 Cells
46. Midnolin is a novel risk factor for Parkinson's Disease and regulates expression of parkin and other causative genes
47. Transcriptome Analysis Reveals That Midnolin Regulates mRNA Expression Levels of Multiple Parkinson’s Disease Causative Genes
48. Possible anti-proliferative effect of TASK-3 on HEK293 and PANC-1 cells
49. Insulin treatment augments KCNQ1/KCNE1 currents but not KCNQ1 currents, which is associated with an increase in KCNE1 expression
50. ALOX12mutation in a family with dominantly inherited bleeding diathesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.